Race Oncology (ASX:RAC) Executes $8.6m Contract for Phase 1 RC220 Trial
Race Oncology (ASX:RAC) secures an $8.6m contract with George Clinical to advance Phase 1 trials of RC220 in solid tumour patients.
Category: Healthcare
Oceania Healthcare (ASX:OCA) Reports FY25 Market Update and Refinancing
Oceania Healthcare (ASX:OCA) reports increased sales, successful $500m debt refinancing, and strategic business optimisations for FY25.
Oceania Healthcare (ASX:OCA) Announces Refinance and Market Update
Oceania Healthcare (ASX:OCA) completes debt refinancing and reports a 29% increase in new sales volumes in its latest market update.
Invion Limited (ASX:IVX) Completes $2M Share Placement to Advance Clinical Programs
Invion Limited (ASX:IVX) successfully raises $2M through a share placement to fund its Phase I/II cancer clinical trials.
Biotron Limited (ASX:BIT) Withdraws Share Purchase Plan and Launches Rights Issue
Biotron Limited (ASX:BIT) withdraws its Share Purchase Plan and announces a $750,000 Rights Issue with Mahe Capital to secure its financial position.
Imricor Medical Systems (ASX:IMR) Submits Second FDA PMA Module
Imricor Medical Systems (ASX:IMR) submits its second FDA PMA module, advancing regulatory progress and preparing for upcoming product launches.
Firebrick Pharma (ASX:FRE) Secures $1.1M Strategic Investment from Philippines Partner
Firebrick Pharma (ASX:FRE) secures a $1.1 million strategic investment from Pharma Nutria N.A., Inc., strengthening its partnership in the Philippines.
Dimerix Limited (ASX:DXB) Receives Initial Upfront Payment from FUSO
Dimerix Limited (ASX:DXB) receives an initial ¥300 million payment from FUSO, with further milestones and potential royalties outlined.
Pro Medicus Limited (ASX:PME) Secures A$40M, 7-Year Contract with LucidHealth
Pro Medicus Limited (ASX:PME) signs a A$40M, 7-year contract with LucidHealth to implement its cloud-based Visage 7 platform.
PainChek Limited (ASX:PCK) Releases Half Year Results
PainChek Limited (ASX:PCK) reports a 27% revenue increase in its half-year results, highlighting growth and expansion into the US market.